Literature DB >> 12650640

MEKK3 interacts with the PA28 gamma regulatory subunit of the proteasome.

Carsten Hagemann1, Rajnikant Patel, Jonathan L Blank.   

Abstract

The proteasome is a multisubunit proteolytic enzyme comprising activator complexes bound to the 20 S catalytic core. The functions of the proteasomal activator (PA) 700 in ubiquitin/ATP-dependent protein degradation and of the PA28 alpha/beta activators in antigen presentation are well defined. However, the function of a third PA, PA28 gamma, remains elusive. We now show that mitogen-activated protein kinase (MAPK)/extracellular-signal-regulated kinase (ERK) kinase kinase 3 (MEKK3), a MAPK kinase kinase (MAPKKK) involved in MAPK kinase 7 (MKK7)-c-Jun N-terminal kinase ('JNK') and MKK6-p38 signalling, can bind PA28 gamma but not PA28 alpha. In contrast, B-Raf, a MAPKKK specific for the MAPK/ERK kinase ('MEK')-ERK module, binds PA28 gamma and alpha. The PA28 gamma-binding domain of MEKK3 is located within its N-terminal regulatory domain (amino acids 1-178). Expression of MEKK3 in Cos-7 cells led to an increase in endogenous and co-expressed PA28 gamma protein levels, whereas kinase-deficient MEKK3 had no effect on PA28 gamma expression. Furthermore, in vitro assays indicated that PA28 gamma was a MEKK3 substrate. MEKK3 represents the first protein kinase capable of binding and phosphorylating a PA, and provides a potential mechanism to link stress-activated protein kinase signalling with the PA28 gamma-dependent proteasome.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12650640      PMCID: PMC1223459          DOI: 10.1042/BJ20021758

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  45 in total

Review 1.  Control of mitotic transitions by the anaphase-promoting complex.

Authors:  G Fang; H Yu; M W Kirschner
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1999-09-29       Impact factor: 6.237

2.  Growth retardation in mice lacking the proteasome activator PA28gamma.

Authors:  S Murata; H Kawahara; S Tohma; K Yamamoto; M Kasahara; Y Nabeshima; K Tanaka; T Chiba
Journal:  J Biol Chem       Date:  1999-12-31       Impact factor: 5.157

3.  Subcellular localization of proteasomes and their regulatory complexes in mammalian cells.

Authors:  P Brooks; G Fuertes; R Z Murray; S Bose; E Knecht; M C Rechsteiner; K B Hendil; K Tanaka; J Dyson; J Rivett
Journal:  Biochem J       Date:  2000-02-15       Impact factor: 3.857

4.  Reconstitution of hybrid proteasomes from purified PA700-20 S complexes and PA28alphabeta activator: ultrastructure and peptidase activities.

Authors:  F Kopp; B Dahlmann; L Kuehn
Journal:  J Mol Biol       Date:  2001-10-26       Impact factor: 5.469

5.  Immunoproteasomes largely replace constitutive proteasomes during an antiviral and antibacterial immune response in the liver.

Authors:  S Khan; M van den Broek; K Schwarz; R de Giuli; P A Diener; M Groettrup
Journal:  J Immunol       Date:  2001-12-15       Impact factor: 5.422

Review 6.  From receptors to stress-activated MAP kinases.

Authors:  H Ichijo
Journal:  Oncogene       Date:  1999-11-01       Impact factor: 9.867

7.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

Review 8.  The ups and downs of MEK kinase interactions.

Authors:  C Hagemann; J L Blank
Journal:  Cell Signal       Date:  2001-12       Impact factor: 4.315

9.  Structural basis for the activation of 20S proteasomes by 11S regulators.

Authors:  F G Whitby; E I Masters; L Kramer; J R Knowlton; Y Yao; C C Wang; C P Hill
Journal:  Nature       Date:  2000-11-02       Impact factor: 49.962

Review 10.  The proteasome activator 11 S REG (PA28) and class I antigen presentation.

Authors:  M Rechsteiner; C Realini; V Ustrell
Journal:  Biochem J       Date:  2000-01-01       Impact factor: 3.857

View more
  13 in total

1.  Subcellular proteomics reveals a role for nucleo-cytoplasmic trafficking at the DNA replication origin activation checkpoint.

Authors:  Claire M Mulvey; Slavica Tudzarova; Mark Crawford; Gareth H Williams; Kai Stoeber; Jasminka Godovac-Zimmermann
Journal:  J Proteome Res       Date:  2013-02-06       Impact factor: 4.466

2.  Involvement of the nuclear proteasome activator PA28γ in the cellular response to DNA double-strand breaks.

Authors:  Adva Levy-Barda; Yaniv Lerenthal; Anthony J Davis; Young Min Chung; Jeroen Essers; Zhengping Shao; Nicole van Vliet; David J Chen; Mickey C-T Hu; Roland Kanaar; Yael Ziv; Yosef Shiloh
Journal:  Cell Cycle       Date:  2011-12-15       Impact factor: 4.534

3.  Glucosamine induces cell death via proteasome inhibition in human ALVA41 prostate cancer cell.

Authors:  Bao-Qin Liu; Xin Meng; Chao Li; Yan-Yan Gao; Ning Li; Xiao-Fang Niu; Yifu Guan; Hua-Qin Wang
Journal:  Exp Mol Med       Date:  2011-09-30       Impact factor: 8.718

Review 4.  Phosphorylation and the Cajal body: modification in search of function.

Authors:  Michael D Hebert
Journal:  Arch Biochem Biophys       Date:  2010-03-01       Impact factor: 4.013

5.  Catenarin Prevents Type 1 Diabetes in Nonobese Diabetic Mice via Inhibition of Leukocyte Migration Involving the MEK6/p38 and MEK7/JNK Pathways.

Authors:  Ming-Yi Shen; Yu-Ping Lin; Bei-Chang Yang; Yu-Song Jang; Chih-Kang Chiang; Clément Mettling; Zeng-Weng Chen; Joen-Rong Sheu; Cicero L Chang; Yea-Lih Lin; Wen-Chin Yang
Journal:  Evid Based Complement Alternat Med       Date:  2012-02-13       Impact factor: 2.629

6.  UV-induced fragmentation of Cajal bodies.

Authors:  Mario Cioce; Séverine Boulon; A Gregory Matera; Angus I Lamond
Journal:  J Cell Biol       Date:  2006-11-06       Impact factor: 10.539

Review 7.  Proteasome subtypes and regulators in the processing of antigenic peptides presented by class I molecules of the major histocompatibility complex.

Authors:  Nathalie Vigneron; Benoît J Van den Eynde
Journal:  Biomolecules       Date:  2014-11-18

Review 8.  Naturally occurring anthraquinones: chemistry and therapeutic potential in autoimmune diabetes.

Authors:  Shih-Chang Chien; Yueh-Chen Wu; Zeng-Weng Chen; Wen-Chin Yang
Journal:  Evid Based Complement Alternat Med       Date:  2015-03-18       Impact factor: 2.629

9.  REG γ knockdown suppresses proliferation by inducing apoptosis and cell cycle arrest in osteosarcoma.

Authors:  Zhiqiang Yin; Hao Jin; Shibo Huang; Guofan Qu; Qinggang Meng
Journal:  PeerJ       Date:  2020-04-15       Impact factor: 2.984

Review 10.  PA28γ, an Accomplice to Malignant Cancer.

Authors:  Kexin Lei; Hetian Bai; Silu Sun; Chuan Xin; Jing Li; Qianming Chen
Journal:  Front Oncol       Date:  2020-10-30       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.